Rationale and Budget Impact of Bimonthly Use of Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer
Head and Neck - United States
doi 10.1002/hed.25481
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 24, 2019
Authors
Publisher
Wiley